Locoregionally recurrent breast cancer: incidence, risk factors and survival.

2.50
Hdl Handle:
http://hdl.handle.net/10541/83335
Title:
Locoregionally recurrent breast cancer: incidence, risk factors and survival.
Authors:
Clemons, Mark; Danson, Sarah; Hamilton, T; Goss, P
Abstract:
Locoregional recurrence (LRR) after therapy for early breast cancer is common. Patients with LRR can suffer both local consequences and symptoms of metastatic disease, as LRR is an independent predictor of subsequent distant metastases. Much of the available data on LRR is derived from small, single institution, retrospective studies, so marked differences in the incidence rates for LRR, it's risk factors and subsequent systemic recurrence are reported. The purpose of this review was to try and collate this data in a format that would be useful for both clinicians and their patients.
Affiliation:
Department of Medical Oncology, Christie Hospital, Wilmslow Road, Manchester, UK. clemonde@breathemail.net
Citation:
Locoregionally recurrent breast cancer: incidence, risk factors and survival. 2001, 27 (2):67-82 Cancer Treat. Rev.
Journal:
Cancer Treatment Reviews
Issue Date:
Apr-2001
URI:
http://hdl.handle.net/10541/83335
DOI:
10.1053/ctrv.2000.0204
PubMed ID:
11319846
Type:
Article
Language:
en
ISSN:
0305-7372
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorClemons, Mark-
dc.contributor.authorDanson, Sarah-
dc.contributor.authorHamilton, T-
dc.contributor.authorGoss, P-
dc.date.accessioned2009-10-02T12:05:35Z-
dc.date.available2009-10-02T12:05:35Z-
dc.date.issued2001-04-
dc.identifier.citationLocoregionally recurrent breast cancer: incidence, risk factors and survival. 2001, 27 (2):67-82 Cancer Treat. Rev.en
dc.identifier.issn0305-7372-
dc.identifier.pmid11319846-
dc.identifier.doi10.1053/ctrv.2000.0204-
dc.identifier.urihttp://hdl.handle.net/10541/83335-
dc.description.abstractLocoregional recurrence (LRR) after therapy for early breast cancer is common. Patients with LRR can suffer both local consequences and symptoms of metastatic disease, as LRR is an independent predictor of subsequent distant metastases. Much of the available data on LRR is derived from small, single institution, retrospective studies, so marked differences in the incidence rates for LRR, it's risk factors and subsequent systemic recurrence are reported. The purpose of this review was to try and collate this data in a format that would be useful for both clinicians and their patients.en
dc.language.isoenen
dc.subjectBreast Canceren
dc.subjectCancer Metastasisen
dc.subjectCancer Recurrenceen
dc.subject.meshAdult-
dc.subject.meshAged-
dc.subject.meshBreast Neoplasms-
dc.subject.meshFemale-
dc.subject.meshHumans-
dc.subject.meshIncidence-
dc.subject.meshMastectomy-
dc.subject.meshMastectomy, Segmental-
dc.subject.meshMiddle Aged-
dc.subject.meshNeoplasm Metastasis-
dc.subject.meshNeoplasm Recurrence, Local-
dc.subject.meshPrognosis-
dc.subject.meshRisk Factors-
dc.subject.meshSurvival Analysis-
dc.titleLocoregionally recurrent breast cancer: incidence, risk factors and survival.en
dc.typeArticleen
dc.contributor.departmentDepartment of Medical Oncology, Christie Hospital, Wilmslow Road, Manchester, UK. clemonde@breathemail.neten
dc.identifier.journalCancer Treatment Reviewsen

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.